Cited by 3,184Cancer Genomics and DiagnosticsCancer-related Molecular PathwaysGenomics and Rare Diseases

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

A census of human cancer genes

Open access

Futreal, P. Andrew, Coin, Lachlan, Marshall, Mhairi, Down, Thomas, Hubbard, Timothy, Wooster, Richard, Rahman, Nazneen, Stratton, Michael R.·2004·Nature Reviews Cancer

DOI 10.1038/nrc1299PMC PMC2665285

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc1299

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Pfam Protein Families Database
Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Self-citation

Show all 44 references

Sorted by citations

Items 201–300 of 1,007

Molecular genetics of multiple endocrine neoplasia types 1 and 2
Marx, S. J. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1610 · Cited by 318
Advances in Chemical Carcinogenesis: A Historical Review and Prospective
Loeb, L. A., & Harris, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2852 · Cited by 325
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Edgren, H., Murumägi, A., Kangaspeska, S., Nicorici, D., Hongisto, V., Sahlberg, K. K., Rye, I. H., Nyberg, S., Wolf, M., Børresen‐Dale, A., et al. (2011) · Genome biology · doi:10.1186/gb-2011-12-1-r6 · Cited by 313
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
Scott, R. H., Stiller, C. A., Walker, L., & Rahman, N. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041723 · Cited by 315
Self-citation
Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013
Huret, J. L., Ahmad, M., Arsaban, M., Bernheim, A., Cigna, J., Desangles, F., Guignard, J.-C., Jacquemot-Perbal, M.-C., Labarussias, M., Leberre, V., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1082 · Cited by 311
The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals
Cao, Y., Li, L., Xu, M., Feng, Z., Sun, X., Lu, J., Xu, Y., Du, P., Wang, T., Hu, R., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0322-9 · Cited by 311
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers
KAUFFMAN, E. C., Ricketts, C. J., Rais‐Bahrami, S., Yang, Y., Merino, M. J., Bottaro, D. P., Srinivasan, R., & Linehan, W. M. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.162 · Cited by 319
Next-generation tag sequencing for cancer gene expression profilingPreprint
Morrissy, A. S., Morin, R. D., Delaney, A. D., Zeng, T., McDonald, H., Jones, S. J. M., Zhao, Y., Hirst, M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.094482.109 · Cited by 309
Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa
Domazet‐Lošo, T., & Tautz, D. (2010) · BMC Biology · doi:10.1186/1741-7007-8-66 · Cited by 311
Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma
Gu, T.-L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V. M., Wang, Y., Deng, G., Zhu, L., Tan, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015640 · Cited by 307
Impact of deleterious passenger mutations on cancer progression
McFarland, C. D., Korolev, K. S., Kryukov, G. V., Sunyaev, S. R., & Mirny, L. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213968110 · Cited by 319
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
Hurst, C. D., Alder, O., Platt, F. M., Droop, A., Stead, L. F., Burns, J. E., Burghel, G. J., Jain, S., Klimczak, L. J., Lindsay, H. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.005 · Cited by 307
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
Clark, M. J., Homer, N., O’Connor, B. D., Chen, Z., Eskin, A., Lee, H., Merriman, B., & Nelson, S. F. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000832 · Cited by 321
Integrative analysis of the melanoma transcriptome
Berger, M. F., Levin, J. Z., Vijayendran, K., Sivachenko, A., Adiconis, X., Maguire, J., Johnson, L. A., Robinson, J., Verhaak, R. G., Sougnez, C., et al. (2010) · Genome Research · doi:10.1101/gr.103697.109 · Cited by 305
The NF1 somatic mutational landscape in sporadic human cancers
Philpott, C., Tovell, H., Frayling, I. M., Cooper, D. N., & Upadhyaya, M. (2017) · Human Genomics · doi:10.1186/s40246-017-0109-3 · Cited by 318
EnrichNet: network-based gene set enrichment analysis
Glaab, E., Baudot, A., Krasnogor, N., Schneider, R., & Valencia, A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts389 · Cited by 311
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
Janne, P. A., Gray, N. S., & Settleman, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2871 · Cited by 312
Proline Metabolism and Microenvironmental Stress
Phang, J. M., Liu, W., & Zabirnyk, O. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104638 · Cited by 303
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Chudasama, P., Mughal, S. S., Sanders, M. A., Hübschmann, D., Chung, I., Deeg, K. I., Wong, S.-H., Rabe, S., Hlevnjak, M., Zapatka, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02602-0 · Cited by 316
IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis
White, C. D., Brown, M. P., & Sacks, D. B. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.007 · Cited by 302
Genomics and evolution of protein phosphatases
Chen, M. J., Dixon, J. E., & Manning, G. (2017) · Science Signaling · doi:10.1126/scisignal.aag1796 · Cited by 309
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
Bashashati, A., Haffari, G., Ding, J., Ha, G., Lui, K., Rosner, J., Huntsman, D. D., Caldas, C., Aparicio, S. A. J. R., & Shah, S. P. (2012) · Genome biology · doi:10.1186/gb-2012-13-12-r124 · Cited by 301
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers
Lin, E., Li, L., Guan, Y., Soriano, R. H., Rivers, C. S., Mohan, S., Pandita, A., Tang, J., & Modrusan, Z. D. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0522 · Cited by 305
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples
Chen, H., Li, C., Peng, X., Zhou, Z., Weinstein, J. N., Johnson, R., Demchok, J. A., Felau, I., Kasapi, M., Ferguson, M. L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.027 · Cited by 300
In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities
Rubio-Perez, C., Tamborero, D., Schroeder, M. P., Antolín, A. A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., Gonzalez-Perez, A., & Lopez-Bigas, N. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.007 · Cited by 296
Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
Lin, W. M., Baker, A. C., Beroukhim, R., Winckler, W., Feng, W., Marmion, J. M., Laine, E., Greulich, H. E., Tseng, H., Gates, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2615 · Cited by 296
Proteogenomic Characterization of Human Early-Onset Gastric Cancer
Mun, D.-G., Bhin, J., Kim, S., Kim, H., Jung, J. H., Jung, Y., Jang, Y. E., Park, J. M., Kim, H., Jung, Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.003 · Cited by 294
The landscape of viral expression and host gene fusion and adaptation in human cancer
Tang, K., Alaei-Mahabadi, B., Samuelsson, T., Lindh, M., & Larsson, E. (2013) · Nature Communications · doi:10.1038/ncomms3513 · Cited by 294
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
Veeriah, S., Brennan, C., Meng, S., Singh, B., Fagin, J. A., Solit, D. B., Paty, P. B., Rohle, D., Vivanco, I., Chmielecki, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900571106 · Cited by 298
Integrated analysis of germline and somatic variants in ovarian cancer
Kanchi, K., Johnson, K. J., Lu, C., McLellan, M. D., Leiserson, M. D. M., Wendl, M. C., Zhang, Q., Koboldt, D. C., Xie, M., Kandoth, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4156 · Cited by 308
Clonal evolution of chemotherapy-resistant urothelial carcinoma
Faltas, B. M., Prandi, D., Tagawa, S. T., Molina, A. M., Nanus, D. M., Sternberg, C. N., Rosenberg, J. E., Mosquera, J. M., Robinson, B. D., Elemento, O., et al. (2016) · Nature Genetics · doi:10.1038/ng.3692 · Cited by 290
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Akdemir, K. C., Le, V. T., Chandran, S., Li, Y., Verhaak, R. G., Beroukhim, R., Campbell, P. J., Chin, L., Dixon, J. R., Futreal, P. A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0564-y · Cited by 283
Self-citation
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Lehmann, B. D., Colaprico, A., Silva, T. C., Chen, J., An, H., Ban, Y. J., Huang, H., Wang, L. H.-C., James, J. L., Balko, J. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26502-6 · Cited by 298
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Herceg, Z., & Hainaut, P. L. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.004 · Cited by 296
dmGWAS: dense module searching for genome-wide association studies in protein–protein interaction networks
Jia, P., Zheng, S., Long, J., Zheng, W., & Zhao, Z. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq615 · Cited by 286
Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics
Gawad, C., Koh, W. L. C., & Quake, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420822111 · Cited by 283
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity
Närvä, E., Autio, R., Rahkonen, N., Kong, L., Harrison, N., Kitsberg, D., Borghese, L., Itskovitz‐Eldor, J., Rasool, O., Dvořák, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1615 · Cited by 281
4E-Binding Protein 1: A Key Molecular “Funnel Factor” in Human Cancer with Clinical Implications
Armengol, G., Rojo, F., Castellví, J., Iglesias, C., Cuatrecasas, M., Pons, B., Baselga, J. M., & y Cajal, S. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0881 · Cited by 279
Retroviral insertional mutagenesis: past, present and future
Uren, A. G., Kool, J., Berns, A. J. M., & van Lohuizen, M. (2005) · Oncogene · doi:10.1038/sj.onc.1209043 · Cited by 278
Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers
Reimand, J., & Bader, G. D. (2013) · Molecular Systems Biology · doi:10.1038/msb.2012.68 · Cited by 274
DawnRank: discovering personalized driver genes in cancer
Hou, J. P., & Ma, J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0056-8 · Cited by 271
Conformational states dynamically populated by a kinase determine its function
Xie, T., Saleh, T., Rossi, P., & Kalodimos, C. G. (2020) · Science · doi:10.1126/science.abc2754 · Cited by 266
A conserved protonation-dependent switch controls drug binding in the Abl kinase
Shan, Y., Seeliger, M. A., Eastwood, M. P., Frank, F., Xu, H., Jensen, M. Ø., Dror, R. O., Kuriyan, J., & Shaw, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811223106 · Cited by 264
A map of human cancer signaling
Cui, Q., Ma, Y., Jaramillo, M., Bari, H., Awan, A., Yang, S., Zhang, S. V., Liu, L., Meng, L., O'Connor‐McCourt, M. D., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100200 · Cited by 260
The kinome 'at large' in cancer
Fleuren, E. D. G., Zhang, L., Wu, J., & Daly, R. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2015.18 · Cited by 268
Predicting the functional consequences of cancer-associated amino acid substitutions
Shihab, H. A., Gough, J., Cooper, D. N., Day, I. N. M., & Gaunt, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt182 · Cited by 259
Differential expression of selected histone modifier genes in human solid cancers
Özdağ, H., Teschendorff, A. E., Ahmed, A. A., Hyland, S. J., Blenkiron, C., Bobrow, L., Veerakumarasivam, A., Burtt, G. J., Subkhankulova, T., Arends, M. J., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-90 · Cited by 266
Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
Schultheis, A. M., Ng, C. K. Y., Filippo, M. R. D., Piscuoglio, S., Macedo, G. S., Gatius, S., Perez‐Mies, B., Soslow, R. A., Lim, R. S., Viale, A. J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv427 · Cited by 257
Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma
Hao, J., Lin, D., Dinh, H. Q., Mayakonda, A., Jiang, Y., Chen, C., Jiang, Y., Lü, C., Shi, Z., Xu, X., et al. (2016) · Nature Genetics · doi:10.1038/ng.3683 · Cited by 259
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
Saal, L. H., Vallon-Christersson, J., Häkkinen, J., Hegardt, C., Grabau, D., Winter, C., Brueffer, C., Tang, M.-H. E., Reuterswärd, C., Schulz, R., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0131-9 · Cited by 255
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis
Hu, Z., Zhou, S., Li, J., Zhou, Z., Wang, P., Xin, H., Mao, L., Luo, C., Yu, S., Huang, X., et al. (2019) · Hepatology · doi:10.1002/hep.31068 · Cited by 253
Lifestyle as risk factor for cancer: Evidence from human studies
Khan, N., Afaq, F., & Mukhtar, H. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.013 · Cited by 258
Raman Imaging in Biochemical and Biomedical Applications. Diagnosis and Treatment of Breast Cancer
Abramczyk, H., & Brożek-Płuska, B. (2013) · Chemical Reviews · doi:10.1021/cr300147r · Cited by 251
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
Chiu, H., Somvanshi, S., Patel, E., Chen, T.-W., Singh, V., Zorman, B., Patil, S. L., Pan, Y., Chatterjee, S. S., Johnson, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.064 · Cited by 251
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
TEIXEIRA, V. H., Pipinikas, C., Pennycuick, A., Lee-Six, H., Chandrasekharan, D. P., Beane, J., Morris, T. J., Karpathakis, A., Feber, A., Breeze, C. E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0323-0 · Cited by 255
A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters
Demircioğlu, D., Cukuroglu, E., Kindermans, M., Nandi, T., Calabrese, C., Fonseca, N. A., Kahles, A., Lehmann, K.-V., Stegle, O., Brazma, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.018 · Cited by 250
Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets
Vinayagam, A., Gibson, T. E., Lee, H., Yilmazel, B., Roesel, C. L., Hu, Y., Kwon, Y. V., Sharma, A., Liu, Y., Perrimon, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603992113 · Cited by 255
DNA secondary structures and epigenetic determinants of cancer genome evolution
De, S., & Michor, F. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2089 · Cited by 252
Fen1 mutations result in autoimmunity, chronic inflammation and cancers
Zheng, L., Dai, H., Zhou, M., Li, M., Singh, P., Qiu, J., Tsark, W. M. K., Huang, Q. M., Kernstine, K. H., Zhang, X., et al. (2007) · Nature Medicine · doi:10.1038/nm1599 · Cited by 255
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer
Morganti, S., Tarantino, P., Ferraro, E., D’Amico, P., Duso, B. A., & Curigliano, G. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-24100-1_2 · Cited by 246
Regulation of DNA End Joining, Resection, and Immunoglobulin Class Switch Recombination by 53BP1
Bothmer, A., Robbiani, D. F., Di Virgilio, M., Bunting, S. F., Klein, I. A., Feldhahn, N., Barlow, J., Chen, H.-T., Bosque, D., Callen, E., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.019 · Cited by 244
Molecular genetics of osteosarcoma
Rickel, K., Fang, F., & Tao, J. (2016) · Bone · doi:10.1016/j.bone.2016.10.017 · Cited by 255
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0197 · Cited by 243
Identification of cancer driver genes based on nucleotide context
Dietlein, F., Weghorn, D., Taylor-Weiner, A. N., Richters, A., Reardon, B. M., Liu, D., Lander, E. S., Allen, E. M. V., & Sunyaev, S. R. (2020) · Nature Genetics · doi:10.1038/s41588-019-0572-y · Cited by 251
Integration Specificity of Phage ϕC31 Integrase in the Human Genome
Chalberg, T. W., Portlock, J. L., Olivares, E. C., Thyagarajan, B., Kirby, P. J., Hillman, R. T., Hoelters, J., & Calos, M. P. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.098 · Cited by 246
Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer
Paci, P., Colombo, T., & Farina, L. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-83 · Cited by 240
Human Cancer Protein-Protein Interaction Network: A Structural Perspective
Kar, G., Gursoy, A., & Keskin, O. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000601 · Cited by 235
SIGNOR: a database of causal relationships between biological entities
Perfetto, L., Briganti, L., Calderone, A., Perpetuini, A. C., Iannuccelli, M., Langone, F., Licata, L., Marinkovic, M., Mattioni, A., Pavlidou, T., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1048 · Cited by 235
Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models
Yousefi, S., Amrollahi, F., Amgad, M. T., Dong, C., Lewis, J. E., Song, C., Gutman, D. A., Halani, S. H., Vega, J. E. V., Brat, D. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11817-6 · Cited by 243
Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
de Castro, D. G., Clarke, P. A., Al‐Lazikani, B., & Workman, P. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.237 · Cited by 237
Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing
Reumers, J., Rijk, P. D., Zhao, H., Liekens, A. M. L., Smeets, D., Cleary, J., Loo, P. V., Bossche, M. J. A. V. D., Catthoor, K., Sabbe, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.2053 · Cited by 239
Diagnosis of fusion genes using targeted RNA sequencing
Heyer, E. E., Deveson, I. W., Wooi, D., Selinger, C. I., Lyons, R. J., Hayes, V. M., O'Toole, S. A., Ballinger, M. L., Gill, D. S., Thomas, D. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09374-9 · Cited by 240
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
Birkenkamp‐Demtröder, K., Nordentoft, I., Christensen, E., Høyer, S., Reinert, T., Vang, S., Borre, M., Agerbæk, M., Jensen, J. B., Orntoft, T. F., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.01.007 · Cited by 231
Recurrent somatic mutations in regulatory regions of human cancer genomes
Melton, C. A., Reuter, J., Spacek, D. V., & Snyder, M. P. (2015) · Nature Genetics · doi:10.1038/ng.3332 · Cited by 243
The genetic landscape of endometrial clear cell carcinomas
DeLair, D. F., Burke, K. A., Selenica, P., Lim, R. S., Scott, S. N., Middha, S., Mohanty, A. S., Cheng, D. T., Berger, M. F., Soslow, R. A., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4947 · Cited by 230
Somatic Mutations of ERBB2 Kinase Domain in Gastric, Colorectal, and Breast Carcinomas
Lee, J. W., Soung, Y. H., Seo, S. H., Kim, S. Y., Park, C. H., Wang, Y. P., Park, K., Nam, S. W., Park, W. S., Kim, S. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0976 · Cited by 228
Non‐solid oncogenes in solid tumors: EML4–ALK fusion genes in lung cancer
Mano, H. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00972.x · Cited by 232
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
Nayar, U., Cohen, O., Kapstad, C., Cuoco, M. S., Waks, A. G., Wander, S. A., Painter, C., Freeman, S. S., Persky, N. S., Marini, L., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0287-5 · Cited by 232
Functional regulation of FEN1 nuclease and its link to cancer
Zheng, L., Jia, J., Finger, L. D., Guo, Z., Zer, C., & Shen, B. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq884 · Cited by 227
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Frankell, A. M., Jammula, S., Li, X., Contino, G., Killcoyne, S., Abbas, S., Perner, J., Bower, L., Devonshire, G., Ococks, E., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0331-5 · Cited by 234
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
Wei, L., Wang, J., Lampert, E. J., Schlanger, S. E., DePriest, A. D., Hu, Q., Gomez, E. C., Murakam, M., Glenn, S. T., Conroy, J. M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.07.008 · Cited by 226
A pan-cancer analysis of synonymous mutations
Sharma, Y., Miladi, M., Dukare, S., Boulay, K., Caudron‐Herger, M., Groß, M., Backofen, R., & Diederichs, S. (2019) · Nature Communications · doi:10.1038/s41467-019-10489-2 · Cited by 229
Integrative pathway enrichment analysis of multivariate omics data
Paczkowska, M., Barenboim, J., Sintupisut, N., Fox, N. S., Zhu, H., Abd-Rabbo, D., Mee, M. W., Boutros, P. C., PCAWG Drivers and Functional Interpretation Working Group, Abascal, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13983-9 · Cited by 236
Chemical approaches to the discovery and development of cancer therapies
Neidle, S., & Thurston, D. E. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1587 · Cited by 224
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy Patterns
Sack, L. M., Davoli, T., Li, M. Z., Li, Y., Xu, Q., Naxerova, K., Wooten, E. C., Bernardi, R. J., Martin, T. D., Chen, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.037 · Cited by 225
A Genome-Wide siRNA Screen Reveals Multiple mTORC1 Independent Signaling Pathways Regulating Autophagy under Normal Nutritional Conditions
Lipinski, M. M., Hoffman, G., Ng, A., Zhou, W., Py, B. F., Hsu, E., Liu, X., Eisenberg, J. M., Liu, J. S., Blenis, J., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.005 · Cited by 229
Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma
Lin, D., Mayakonda, A., Dinh, H. Q., Huang, P., Lin, L., Liu, X., Ding, L., Wang, J., Berman, B. P., Song, E., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2822 · Cited by 223
Intellectual Property Landscape of the Human Genome
Jensen, K. L., & Murray, F. (2005) · Science · doi:10.1126/science.1120014 · Cited by 221
Architecture of inherited susceptibility to common cancer
Fletcher, O., & Houlston, R. S. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2840 · Cited by 227
The Protein Interaction Landscape of the Human CMGC Kinase Group
Varjosalo, M. T., Keskitalo, S., van Drogen, A., Nurkkala, H., Vichalkovski, A., Aebersold, R. H., & Gstaiger, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.027 · Cited by 235
Translating Tumor Antigens into Cancer Vaccines
Buonaguro, L., Petrizzo, A., Tornesello, M. L., & Buonaguro, L. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00286-10 · Cited by 229
The Proteomic Landscape of Triple-Negative Breast Cancer
Lawrence, R., Perez, E. M., Hernández, D., Miller, C. P., Haas, K. M., Irie, H. Y., Lee, S., Blau, C. A., & Villén, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.050 · Cited by 225
Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening
Esposito, R., Bosch, N., Lanzós, A., Polidori, T., Pulido-Quetglas, C., & Johnson, R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.019 · Cited by 223
Comprehensive assessment of cancer missense mutation clustering in protein structures
Kamburov, A., Lawrence, M. S., Polak, P. P., Leshchiner, I., Lage, K., Golub, T. R., Lander, E. S., & Getz, G. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516373112 · Cited by 222
Top‐down proteomics in health and disease: Challenges and opportunities
Gregorich, Z. R., & Ge, Y. (2014) · PROTEOMICS · doi:10.1002/pmic.201300432 · Cited by 217
KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer
Tie, J., Lipton, L., Desai, J., Gibbs, P., Jorissen, R. N., Christie, M., Drummond, K. J., Thomson, B. N. J., Usatoff, V., Evans, P. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1720 · Cited by 217
Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion
Xi, R., Hadjipanayis, A. G., Luquette, L. J., Kim, T., Lee, E., Zhang, J., Johnson, M. D., Muzny, D. M., Wheeler, D. A., Gibbs, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110574108 · Cited by 221
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
Neumann, M., Heesch, S., Schlee, C., Schwartz, S., Gökbuget, N., Hoelzer, D. F., Konstandin, N. P., Ksienzyk, B., Vosberg, S., Graf, A., et al. (2013) · Blood · doi:10.1182/blood-2012-11-465138 · Cited by 221
A genome-wide positioning systems network algorithm for in silico drug repurposing
Cheng, F., Lu, W., Liu, C., Fang, J., Hou, Y., Handy, D. E., Wang, R., Zhao, Y., Yang, Y., Huang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10744-6 · Cited by 215
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
de Castro, I. P., de Cárcer, G., & Malumbres, M. (2006) · Carcinogenesis · doi:10.1093/carcin/bgm019 · Cited by 222

Authors: Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R.
Affiliations: Wellcome Sanger Institute (GB)
Institute of Cancer Research (GB)
Corresponding author: Stratton, Michael R.
ORCID: Futreal, P. Andrew
Coin, Lachlan
Down, Thomas
Rahman, Nazneen
Stratton, Michael R.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2004-03
Volume: 4
Issue: 3
Pages: 177-183
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1299
PMC: PMC2665285
OpenAlex: W2102140136
Cited by: 3,184
References: 44
Citations by year: 2026: 13 · 2025: 51 · 2024: 71 · 2023: 134 · 2022: 109 · 2021: 143 · 2020: 166 · 2019: 204 · 2018: 237 · 2017: 190 · 2016: 191 · 2015: 228 · 2014: 201 · 2013: 208 · 2012: 164
FWCI: 7.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: cancer genes, oncogenes, tumor suppressor, oncogenic mutations, mutation frequency, human genome, protein domains, cancer classification
MeSH terms: Genes, Humans, Mutation, Neoplasms, Oncogenes, Genome, Human

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A census of human cancer genes

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks